Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001238403-23-000002

Director sold 8,638 shares at $23.01 ($198,760)

  • Director acquired 15,151 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
SPIEGELMAN DANIEL K Director 2023-06-01 Grant or award +15,151 49,131 D
SPIEGELMAN DANIEL K Director 2023-06-02 Sale −8,638 $23.01 $198,760 40,493 D
Open-market sales · 8,638 sh · avg $23.01 · $198,760
Loading xslF345X04/wk-form4_1685744119.xml…